China YCT International Group, Inc.
Share StructureMarket Value1 $14,787,762 a/o Mar 05, 2013
Shares Outstanding 29,575,523 a/o Feb 11, 2013
China YCT International Group, Inc. (CYIG), was formerly itLinkz Group, Inc. until November 2007 and is based in Sishui County, the People's Republic of China. CYIG is involved in the development, production and the sales of Gingko and other dietary products. The company wants to have an international brand called YongChunTang. In China alone, there are over 30 branches of the company. There are over 300 distributors and even a branch of the company located in Russia.
Huoliyuan, which is a capsule made by the company is used for the treatment of diabetes, insomnia, memory loss, as well as many other problems. This company has approximately 10 supplement products.
CYIG also owns Shandong Spring Pharmaceutical Co., Ltd. Shandong Spring Pharmaceutical Company, serves as the distributor for Shandong YCT.
Description: China YCT International Group (CYIG), through its wholly owned subsidiary, Landway Nano Bio-Tech Group, Inc., is engaged in the business of developing, manufacturing and marketing gingko, and other dietary supplement products in the People?s Republic of China. The Company owns 100% of Shandong Spring Pharmaceutical Co., Ltd. (Shandong Spring Pharmaceutical). Shandong Spring Pharmaceutical distributes products manufactured by Shandong Yong Chun Tang Bioengineering Co., Ltd. The Company has over 30 branches in China, as well as a branch in Russia, and more than 300 distributors. Shandong Spring Pharmaceutical was originally organized as a subsidiary of Shandong YCT for the purpose of focusing on advanced technology related to the use of gingko as an aide to health. The Company's new product is the Huoliyuan Capsule.
Updated on 2013-02-20 05:48:02
Industry: Pharmaceuticals - Generic & Specialty China YCT International Group, Inc. (CYIG) is registered and established in Florida (FL), United States of America (U.S.A.) on January 1989. The Company through more than a decade of development has become an international Research and Development (R&D), production and sales of Gingko nutraceutical health products, and also pharmaceutical as a whole modern high-tech enterprise group. The Company always adhere to scientific and technological innovation, continually enhance its market competitiveness and competitive advantages, lay eyes and actively exploring the international market, resort to abundant and solid strength and also international leading edge science and technology, thus successfully carried out the company's business expansion and capital operation. http://chinasecurities.com/ir/ChinaYCTInternational/profile
China YCT International Group Inc Management
Chairman of the Board and Chief Executive Officer
Yan Tinghe has over twenty years of experience in corporate management within the food and food supplements industries. Having founded Shandong Spring Pharmaceuticals, he has served as its Chairman since January 2006. During the eight years prior to founding Shandong Spring Pharmaceutical, Mr. Yan was employed as Chairman and General Manager of Shandong Yong Chun Tang Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the period from 1988 to 1997 Mr. Yan served as Executive Vice President of Shishui Sanyin Company, and from 1985 to 1987 as Factory Director of Beijing Shishui Lianhe Preserved Fruits, both of which were multi-facility enterprises in the food industry.
President and Chief Financial Officer
Zhang Jirui brings over twenty years of technical training to Shandong Spring Pharmaceutical, where he has been employed as Director since January 2006. During 2005 Mr. Zhang was the Manager of the International Market Department for Shandong Yong Chun Tang Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the 22 years prior to joining Shandong Yong Chun Tang Bioengineering Co., Ltd., Mr. Zhang was employed as an Instructor in the Shandong Chemical Engineering Vocational School
Bai Junying, Ph.D. in Pharmacy, age 50, was appointed as an independent director of China YCT International Group on April 6, 2009. Over the last twenty years, Dr. Bai has held senior management roles in several companies, including as CEO of Shandong Dong-e E-jiao Group, CEO of Shandong Xinhua Pharmaceutical Co., Ltd., and head of the research and development department and subsequently vice executive manager of Lukang Pharmaceutical Group Co., Ltd. Dr. Bai is currently the CEO of Shandong Dong E-jiao Group, a national well-know pharmaceutical and health care group. From 2000 to 2005, while Dr. Bai served at Shandong Xinhua Pharmaceutical Group Co., Ltd, where he was responsible for the daily operation of the company. Dr. Bai successfully brought the company public and helped develop the company into one of the leading pharmaceutical companies in China. As Head of the R&D Department at Lukang Pharmaceutical Group from 1987 to 2000, Dr. Bai played a central role in the integration and development of an antibiotic injection agent, which made Lukang Pharmaceutical Group a national research center for antibiotics. In 1990, Dr. Bai obtained his Ph.D. in Pharmacy from Beijing University Health Science Center.
Jeremy P. Feakins
Mr. Feakins was originally elected to the Company's board in April of 1996. Since 1989, he has served as President of Medical Technology, Inc. (MTI) and in October 1995, became the President and Chief Executive Officer of Itlinkz. In October 2004 Mr. Feakins founded Care Recruitment Solutions International, Inc., which was engaged in the business of international placement of nurses. Mr. Feakins served as Chief Executive Officer of Care Recruitment Solutions, Inc. and its successor, CRSI Group, Inc. until August 2006, when it terminated its nurse placement operations. He continues to serve as a member of the Board of Directors of Caspian International Oil Corporation (Pink Sheets: CIOC), which is the successor to CRSI Group, Inc. From 2002 until 2004 Mr. Feakins was also employed as a Managing Member of Steridyne Industries, LLC., an importer of medical devices. Steridyne filed for a Chapter 7 liquidation in bankruptcy in December 2004 after Hurricanes Francis and Charley damaged Steridyne's warehouse in Florida and destroyed its inventory. Since 1995, Mr. Feakins has also served as Chairman of Growth Capital Resources, LLC a venture capital and management consulting firm. From 1980 to 1986, he was the managing Director of Craft Master, Limited, a South African corporation, which was a manufacturer and exporter of point of purchase display systems. Mr. Feakins received his degree in accounting from the Royal Naval Secretarial and Accounting College, Chatham, Great Britain. On October 29, 2007 Itlinkz Group entered into a Stock Purchase Agreement with Jeremy Feakins and Growth Capital Resources LLC. Mr. Feakins is a member of the Board of Directors of Itlinkz Group, and was its Chief Executive Officer until September 28, 2007. Mr. Feakins is the managing member of Growth Capital Resources, LLC.
Robert J. Fanella
Effective on April 6, 2009, the members of the Board appointed Mr. Robert J. Fanella as a director. Robert J. Fanella, CPA, 58 years old, was appointed to the post of the company's independent directors. During Mr. Fanella's more than 35 year career specializing in corporate finance and accounting, he was responsible for audit and financial service oversight for both private and public traded companies world-wide, national and regional accounting and financial analysis and service. From 2008 to the present, Mr. Fanella has served as a senior consultant to an Illinois based LED Lighting Manufacturer, providing advice regarding capital raising affairs, capitalization at both the subsidiary and corporate level, and day-to-day financial operations. From 2006 to 2007, Mr. Fanella served as a senior consultant at Chicago Industrial Plating Manufacturer, a more than 100 year old family owned company. In that position, Mr. Fanella was responsible for the resolving company's short-term gap financing issues and working with external auditors to finalize the annual financial report. Prior to that, from 2001 to 2006, Mr. Fanella was co-owner and CFO of Tru-Way, Inc. During his tenure, Mr. Fanella successfully conducted some acquisition deals and helped the company achieve annual revenue growth. From 1983 to 2001, Mr. Fanella was a co-founder and CFO of Microenergy, Inc. At Microenergy, Inc., Mr. Fanella shared with the President total responsibility for all operations of the organization. As the CFO, Mr. Fanella was also responsible for all accounting and SEC filings. Mr. Fanella earned his Bachelor Degree in Finance from North Illinois University in 1972, and he became a Certified Public Accountant in 1975. In 1979, Mr. Fanella received his MBA from the University of Chicago, specializing in Finance & Marketing.
NEXT CHLO +6,122% gain Or WUHN +1,039% gain ---> China YCT International Group Inc (CYIG)
1. China YCT Inc has over 280 employees & a Low Float
2. Current Market Cap is only $88,000... Yes! you read that right eighty-eight thousand dollars!
3. Revenues: 9 months ending December, 2012 were over $23.5 million
4. Net Income: 9 months ending December, 2012 were over $13 million a 528.5% INCREASE over net income for the same period in 2011!
5. Over $27.3 Million in CASH on it's balance sheet!
6. Total Assets of over $57.5 Million with just $2.4 million of liabilities
CYIG through its subsidiaries, engages in developing, manufacturing, and marketing gingko and other dietary supplement products in the Peoples Republic of China. It provides Huoliyuan capsule for the treatment of chronic hepatitis, diabetes, insomnia, memory loss, menopause syndrome, and other maladies. The company also offers 10 health care supplement products. It markets its products through a network of dealers. The company is based in Sishui County, the Peoples Republic of China.
CYIG has become a high-tech, international enterprise specializing in the Research and Development (R&D), production and sales of Gingko nutraceutical health products. The Company continually enhances its market competitiveness and competitive advantages through scientific and technological innovation.
CYIG is devoted to the goal of a healthy lifestyle for the Chinese people as seen in its:
Enterprise mission: To share healthy living and lead development in the gingko industry
Enterprise spirit: To constantly strive for self-improvement through hard work, dedication, wisdom, creativity and innovation
Enterprise target: To build an international YongChunTang brand
Presently, CYIG has over 30 branches in China, as well as a branch in Russia, and more than 300 distributors. Working toward globalization, the Company has built a strong base with its domestic supply chain and sales network while actively pursuing an international development strategy to expand CYIG's products and services in the international market. CYIG is a dynamic, thriving enterprise that is leading China's nutraceutical industry into the future by giving investors and society the highest level of returns.
Ginkgo Biloba is an herb that has been used medicinally for thousands of years. A fundamental ingredient in most Traditional Chinese Medicine, Ginkgo is now one of the top selling herbs in the US. Ginkgo is also one of the most well researched herbs in the world and is currently under scientific study for the treatment of many illnesses. Studies have already shown that Gingko supports healthy circulation to both the brain and extremities of the body by increasing blood flow and decreasing the viscosity of blood. Improved brain circulation has also been tied to improved cognitive function, specifically increased mental sharpness and decreased mild memory problems associated with age. Ginkgo also provides antioxidant properties that help fight cell-damaging free radicals in the body. Overall, Ginkgo is a popular herb that is well tolerated and widely used for medicinal purposes and new uses are being discovered every day.
CYIG currently has a full line of Ginkgo Biloba products from healthy foods, nutritial foods, health supplies, cosmetics, & commodity items.
Innovation Through Research & Development
CYIG leverages R&D to create a competitive advantage through improved product technology and reduced costs. CYIG appropriates 2.5-3% of sales to R&D expenditures and special inventive measures for technological achievements.
In August 2005, the Company acquired China Shandong Spring Pharmaceutical Co., Ltd., a modern high-tech pharmaceutical manufacturing enterprise in Shandong Province, Jining City. Shandong specializes in the R&D and production of nutraceutical health products, tablets, capsules, and thrombolytic injections. It has two major R&D institutions - Shandong Province Enterprise Technology Center and Shandong Province Ginkgo Engineering Research Center - that are equipped with advanced production and processing equipment and world-class testing equipment for quality control, ensuring all products meet international quality standards and requirements.
| || |
|01/25/2010 9:34 ||China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People's Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd. |
|06/30/2009 15:27 ||China YCT International Group, Inc. Announces Financial Results for Fourth Quarter and Fiscal Year 2009 |
|03/13/2009 16:11 ||China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors |
|02/18/2009 11:27 ||China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results |
|01/26/2009 10:24 ||China YCT International Group Inc. (CYIG), Pre-Announces Higher Than Expected Fiscal Year 2009 Third Quarter Earnings |
|01/08/2009 10:23 ||/ CORRECTION - China YCT International, Inc. |
|01/08/2009 10:11 ||China YCT International (CYIG) Announces Its Subsidiary Has Been Selected as One of the Top 10 Enterprises in Bioengineering in the Shandong Province |
|04/07/2008 13:20 ||China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier |
|12/10/2007 16:18 ||CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise" |
|05/02/2007 10:31 ||itLinkz Group Social Networking Website for Golfers to Feature Access to Information on the 2007 Wachovia Championship |
|04/30/2007 10:30 ||itLinkz Group, Inc. Announces Launch of Equestrian Linkup as Successful Expansion of Niche-Focused Online Social Networks Continues |
|04/10/2007 10:13 ||itLinkz Continues Social Network Expansion with Launch of Golfer Linkup |
|03/29/2007 10:44 ||Medical Technology and Innovations, Inc. (MTIV) Announces Appointment of Ric Kern as a Member of the Board of Directors |
c/o Shandong Spring Pharmaceutical Co.
Economic Development Zone
Gucheng Road, Sishui County
Shandong Province 273200
About Shandong Spring Pharmaceutical Co. Ltd. Spring Pharmaceutical Health Care Products Cooperation Project
Interwest Transfer Co., Inc.
1981 East 4800 South
Salt Lake City, UT, 84117